Repeat Serum Testosterone Measurement
The next step is to repeat the early morning serum total testosterone measurement before initiating any treatment. A single low testosterone reading is insufficient to diagnose hypogonadism and initiate testosterone replacement therapy 1.
Diagnostic Rationale
The 2025 European Association of Urology guidelines clearly define male hypogonadism as requiring both symptoms AND biochemical evidence of testosterone deficiency 1. While this patient presents with classic symptoms (erectile dysfunction, reduced libido, absent morning erections), you have only one testosterone measurement of 250 ng/dL.
Why Confirmation is Mandatory
- Testosterone levels fluctuate significantly due to circadian rhythm, stress, acute illness, and laboratory variability
- A single measurement has insufficient diagnostic accuracy
- The patient has hypothyroidism on levothyroxine, which can affect testosterone levels and sexual function 2, 3
- His TSH is normal (3.2), but thyroid dysfunction itself can cause erectile dysfunction independent of testosterone status 2
The Confirmation Process
Obtain a second early morning (before 10 AM) total testosterone level, ideally within 1-2 weeks:
- If the repeat value is also low (<300 ng/dL), hypogonadism is confirmed
- If normal, consider other causes of his symptoms, particularly thyroid-related sexual dysfunction
- The early morning timing is critical as testosterone peaks between 8-10 AM
What Comes After Confirmation
Once hypogonadism is biochemically confirmed with two low measurements:
Then order FSH and LH to distinguish primary (testicular) from secondary (hypothalamic-pituitary) hypogonadism 1. This classification determines:
- Underlying etiology
- Fertility implications
- Treatment approach
- Need for additional pituitary evaluation
Treatment Considerations Post-Diagnosis
If confirmed hypogonadal, the American College of Physicians recommends discussing testosterone treatment for sexual dysfunction, including potential benefits, harms, and costs 4. The 2025 evidence shows testosterone therapy improves sexual function, body composition, and metabolic profile without increasing cardiovascular or prostate cancer risk 5.
However, PDE5 inhibitors alone are NOT appropriate first-line therapy when testosterone is truly low. Phosphodiesterase-5 inhibitors work poorly in the hypogonadal state because adequate testosterone is required for their mechanism of action 6, 7. Many men require both testosterone replacement AND PDE5 inhibitors for optimal erectile function 6.
Critical Pitfall to Avoid
Do not start testosterone replacement based on a single low value. This is a common error that leads to:
- Unnecessary lifelong treatment
- Suppression of endogenous production
- Fertility impairment
- Missing alternative diagnoses (particularly inadequately treated hypothyroidism)
The patient's hypothyroidism deserves attention—thyroid dysfunction directly causes erectile dysfunction through both central neuroendocrine and peripheral vascular mechanisms 3. His current levothyroxine dose (50 mcg) may be suboptimal despite the "normal" TSH of 3.2, as optimal TSH for symptom resolution is often in the lower half of the reference range 8.